We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
151
Union Pacific
UNP
$183B
$25.5M 0.14%
+122,468
New +$24.5M
AVGO icon
152
Broadcom
AVGO
$1.82T
$25.4M 0.14%
579,970
-41,840
-7% -$1.63M
TPR icon
153
Tapestry
TPR
$28.8B
$25.4M 0.14%
816,471
+470,327
+136% +$11.9M
COST icon
154
Costco
COST
$415B
$25.4M 0.14%
67,320
-56,693
-46% -$21.2M
QURE icon
155
uniQure
QURE
$2.68B
$25.3M 0.14%
701,084
-836,821
-54% -$35.3M
ALBO
156
DELISTED
Albireo Pharma Inc
ALBO
$25M 0.14%
667,703
-25,832
-4% -$939K
IWO icon
157
PUT
iShares Russell 2000 Growth ETF
IWO
$14.5B
$25M 0.14%
+87,300
New +$22.2M
EMB icon
158
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$24.9M 0.13%
+214,600
New +$24.3M
TTD icon
159
Trade Desk
TTD
$8.13B
$24.6M 0.13%
+307,660
New +$23.2M
SGEN
160
DELISTED
Seagen Inc. Common Stock
SGEN
$24.6M 0.13%
140,247
+137,330
+4,708% +$25.6M
FISV
161
Fiserv Inc
FISV
$27.2B
$24.4M 0.13%
214,343
+59,225
+38% +$6.38M
ETSY icon
162
Etsy
ETSY
$7.65B
$23.4M 0.13%
131,404
+103,875
+377% +$15.6M
IYR icon
163
PUT
iShares US Real Estate ETF
IYR
$4.59B
$23.3M 0.13%
+271,500
New +$22.6M
TT icon
164
Trane Technologies
TT
$106B
$23.1M 0.12%
158,844
+85,439
+116% +$11.8M
NEE.PRP
165
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
$22.9M 0.12%
450,000
OTIS icon
166
Otis Worldwide
OTIS
$27.4B
$22.8M 0.12%
337,111
-537,634
-61% -$34.9M
V icon
167
Visa
V
$677B
$22.8M 0.12%
104,051
+75,998
+271% +$15.6M
EEM icon
168
iShares MSCI Emerging Markets ETF
EEM
$28B
$22.4M 0.12%
433,126
+186,747
+76% +$8.98M
ACIA
169
DELISTED
Acacia Communications Inc
ACIA
$22.2M 0.12%
303,802
-189,608
-38% -$13.1M
BEKE icon
170
KE Holdings
BEKE
$16.8B
$22.1M 0.12%
359,016
+353,308
+6,190% +$23.5M
ARWR icon
171
Arrowhead Research
ARWR
$12.1B
$22.1M 0.12%
+287,817
New +$18.4M
TRTN
172
DELISTED
Triton International Limited
TRTN
$22M 0.12%
453,905
-53,340
-11% -$2.26M
EXAS
173
DELISTED
Exact Sciences
EXAS
$21.9M 0.12%
+165,401
New +$20M
AFL icon
174
Aflac
AFL
$63.9B
$21.8M 0.12%
490,522
+286,532
+140% +$11.7M
FIT
175
DELISTED
Fitbit, Inc. Class A common stock
FIT
$21.8M 0.12%
3,204,903
+837,779
+35% +$5.91M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.